Emergent BioSolutions Inc. (NYSE:EBS) Q3 2024 Earnings Call Transcript November 6, 2024
Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $1.37, expectations were $0.14.
Operator: Thank you for standing by. My name is Kris and I will be your conference operator today. At this time, I would like to welcome everyone to the Q3 2024 Emergent BioSolutions Inc. Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’...
